Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/17644
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLee, Erinna F-
dc.contributor.authorPerugini, Matthew A-
dc.contributor.authorPettikiriarachchi, Anne-
dc.contributor.authorEvangelista, Marco-
dc.contributor.authorKeizer, David W-
dc.contributor.authorYao, Shenggen-
dc.contributor.authorFairlie, W Douglas-
dc.date.accessioned2018-05-02T23:36:37Z-
dc.date.available2018-05-02T23:36:37Z-
dc.date.issued2016-
dc.identifier.citationAutophagy 2016; 12(3): 460-471-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/17644-
dc.description.abstractBECN1/Beclin 1 has a critical role in the early stages of autophagosome formation. Recently, structures of its central and C-terminal domains were reported, however, little structural information is available on the N-terminal domain, comprising a third of the protein. This lack of structural information largely stems from the inability to produce this region in a purified form. Here, we describe the expression and purification of the N-terminal domain of BECN1 (residues 1 to 150) and detailed biophysical characterization, including NMR spectroscopy. Combined, our studies demonstrated at the atomic level that the BECN1 N-terminal domain is intrinsically disordered, and apart from the BH3 subdomain, remains disordered following interaction with a binding partner, BCL2L1/BCL-XL. In addition, the BH3 domain α-helix induced upon interaction with BCL2L1 reverts to a disordered state when the complex is dissociated by exposure to a competitive inhibitor. No significant interactions between N- and C-terminal domains were detected.-
dc.language.isoeng-
dc.subjectBCL2-
dc.subjectBECN1-
dc.subjectBH3 domain-
dc.subjectBeclin 1-
dc.subjectautophagy-
dc.subjectintrinsically disordered protein; nuclear magnetic resonance-
dc.titleThe BECN1 N-terminal domain is intrinsically disordered.-
dc.typeJournal Article-
dc.identifier.journaltitleAutophagy-
dc.identifier.affiliationThe Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia-
dc.identifier.affiliationDepartment of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia-
dc.identifier.affiliationOlivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia-
dc.identifier.affiliationSchool of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia-
dc.identifier.affiliationBio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, Australia-
dc.identifier.affiliationDepartment of Chemistry and Physics, La Trobe Institute for Molecular Science, Melbourne, Victoria, Australia-
dc.identifier.doi10.1080/15548627.2016.1140292-
dc.identifier.pubmedid27046249-
dc.type.austinJournal Article-
dc.type.austinResearch Support, Non-U.S. Gov't-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.languageiso639-1en-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

10
checked on Oct 2, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.